These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38029797)

  • 61. Is previous azithromycin treatment associated with azithromycin resistance in
    Clifton S; Town K; Furegato M; Cole M; Mohammed H; Woodhall SC; Kevin Dunbar J; Fifer H; Hughes G
    Sex Transm Infect; 2018 Sep; 94(6):421-426. PubMed ID: 29511067
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Resistance profiles of Neisseria gonorrhoeae isolates in Vienna, Austria: a phenotypic and genetic characterization from 2013 to 2020.
    Geusau A; Chromy D; Heissenberger D; Lippert K; Eder C; Heger F; Indra A; Willinger B; Pleininger S
    Int J Antimicrob Agents; 2022; 60(5-6):106656. PubMed ID: 35988663
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012.
    Mlynarczyk-Bonikowska B; Serwin AB; Golparian D; Walter de Walthoffen S; Majewski S; Koper M; Malejczyk M; Domeika M; Unemo M
    BMC Infect Dis; 2014 Feb; 14():65. PubMed ID: 24502606
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genomic Characterization of Neisseria gonorrhoeae Strains from 2016 U.S. Sentinel Surveillance Displaying Reduced Susceptibility to Azithromycin.
    Schmerer MW; Abrams AJ; Seby S; Thomas JC; Cartee J; Lucking S; Vidyaprakash E; Pham CD; Sharpe S; Pettus K; St Cyr SB; Torrone EA; Kersh EN; ; Gernert KM;
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071056
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Decreased Azithromycin Susceptibility of Neisseria gonorrhoeae Isolates in Patients Recently Treated with Azithromycin.
    Wind CM; de Vries E; Schim van der Loeff MF; van Rooijen MS; van Dam AP; Demczuk WHB; Martin I; de Vries HJC
    Clin Infect Dis; 2017 Jul; 65(1):37-45. PubMed ID: 28510723
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Travel-associated lineages and unique endemic antimicrobial-susceptible lineages of
    Al Suwayyid BA; Haese EC; Mowlaboccus S; Pearson JC; Whiley DM; Armstrong PK; Giele CM; Mak DB; Bastian L; Wise MJ; Coombs GW; Kahler CM
    Microb Genom; 2023 Mar; 9(3):. PubMed ID: 36988578
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Neisseria gonorrhoeae 23S rRNA A2059G mutation is the only determinant necessary for high-level azithromycin resistance and improves in vivo biological fitness.
    Zhang J; van der Veen S
    J Antimicrob Chemother; 2019 Feb; 74(2):407-415. PubMed ID: 30376120
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Increasing prevalence of Neisseria gonorrhoeae with decreased susceptibility to ceftriaxone and resistance to azithromycin in Hangzhou, China (2015-17).
    Yan J; Xue J; Chen Y; Chen S; Wang Q; Zhang C; Wu S; Lv H; Yu Y; van der Veen S
    J Antimicrob Chemother; 2019 Jan; 74(1):29-37. PubMed ID: 30329062
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Emergence of decreased susceptibility and resistance to extended-spectrum cephalosporins in Neisseria gonorrhoeae in Korea.
    Lee H; Unemo M; Kim HJ; Seo Y; Lee K; Chong Y
    J Antimicrob Chemother; 2015 Sep; 70(9):2536-42. PubMed ID: 26084303
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
    Kovari H; de Melo Oliveira MD; Hauser P; Läuchli S; Meyer J; Weber R; Zbinden R
    BMC Infect Dis; 2013 Dec; 13():603. PubMed ID: 24369054
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antimicrobial susceptibility of
    Salmerón P; Viñado B; El Ouazzani R; Hernández M; Barbera MJ; Alberny M; Jané M; Larrosa N; Pumarola T; Hoyos-Mallecot Y; Serra-Pladevall J
    Euro Surveill; 2020 Oct; 25(42):. PubMed ID: 33094716
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Projecting the development of antimicrobial resistance in Neisseria gonorrhoeae from antimicrobial surveillance data: a mathematical modelling study.
    Riou J; Althaus CL; Allen H; Cole MJ; Grad YH; Heijne JCM; Unemo M; Low N
    BMC Infect Dis; 2023 Apr; 23(1):252. PubMed ID: 37081443
    [TBL] [Abstract][Full Text] [Related]  

  • 73. First Case of High-Level Azithromycin-Resistant Neisseria gonorrhoeae in North Carolina.
    Palavecino EL; Kilic A; Schmerer MW; Dobre-Buonya O; Toler C; McNeil CJ
    Sex Transm Dis; 2020 May; 47(5):326-328. PubMed ID: 32073548
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013.
    Lebedzeu F; Golparian D; Titov L; Pankratava N; Glazkova S; Shimanskaya I; Charniakova N; Lukyanau A; Domeika M; Unemo M
    BMC Infect Dis; 2015 Jan; 15():29. PubMed ID: 25637258
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The third nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2016-2017.
    Yasuda M; Takahashi S; Miyazaki J; Wada K; Kobayashi K; Matsumoto M; Hayami H; Yamamoto S; Kiyota H; Sato J; Matsumoto T; Yotsuyanagi H; Hanaki H; Masumori N; Hiyama Y; Nishiyama H; Kimura T; Yamada H; Matsumoto K; Ishikawa K; Togo Y; Tanaka K; Sadahira T; Inokuchi J; Hamasuna R; Ito K; Hirayama H; Hayashi K; Kurimura Y; Kadena H; Ito S; Shiono Y; Maruyama T; Ito M; Hatano K; Chokyu H; Ihara H; Uno S; Monden K; Yokoyama T; Kano M; Kaji S; Kawahara M; Sumii T; Tojo T; Hosobe T; Naito K; Kawai S; Nishimura H; Izumitani M; Yoh M; Matsumura M; Fujita R; Takayama K; Hara M; Nishi S
    J Infect Chemother; 2023 Nov; 29(11):1011-1016. PubMed ID: 37553046
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Antimicrobial Resistance of Neisseria Gonorrhoeae in a Newly Implemented Surveillance Program in Uganda: Surveillance Report.
    Workneh M; Hamill MM; Kakooza F; Mande E; Wagner J; Mbabazi O; Mugasha R; Kajumbula H; Walwema R; Zenilman J; Musinguzi P; Kyambadde P; Lamorde M; Manabe YC
    JMIR Public Health Surveill; 2020 Jun; 6(2):e17009. PubMed ID: 32519969
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Emergence of a predominant sequence type ST7363 and the increasing trend of resistance to cefixime and ceftriaxone in Neisseria gonorrhoeae in Southern Taiwan, 2019-2021.
    Lin HH; Li JW; Yang TY; Lee CY; Jain SH; Lin SY; Lu PL
    J Microbiol Immunol Infect; 2023 Aug; 56(4):833-841. PubMed ID: 37002111
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Emergence and characterization of Neisseria gonorrhoeae isolates with decreased susceptibilities to ceftriaxone and cefixime in Canada: 2001-2010.
    Martin I; Sawatzky P; Allen V; Hoang L; Lefebvre B; Mina N; Wong T; Gilmour M
    Sex Transm Dis; 2012 Apr; 39(4):316-23. PubMed ID: 22421701
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Antimicrobial resistance of Neisseria gonorrhoeae in Germany: low levels of cephalosporin resistance, but high azithromycin resistance.
    Buder S; Dudareva S; Jansen K; Loenenbach A; Nikisins S; Sailer A; Guhl E; Kohl PK; Bremer V;
    BMC Infect Dis; 2018 Jan; 18(1):44. PubMed ID: 29343220
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High-level azithromycin resistance occurs in Neisseria gonorrhoeae as a result of a single point mutation in the 23S rRNA genes.
    Chisholm SA; Dave J; Ison CA
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3812-6. PubMed ID: 20585125
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.